Q1 2023 Holdings
Filed 2023-05-15 | 35 holdings | $774.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $162.0M | 2,918,237 | 20.9% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $119.5M | 1,094,620 | 15.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $67.7M | 3,205,986 | 8.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $50.7M | 1,409,451 | 6.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $45.6M | 1,216,784 | 5.9% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $38.1M | 3,738,972 | 4.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $35.2M | 1,563,595 | 4.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $31.6M | 1,375,000 | 4.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $26.2M | 3,372,428 | 3.4% |
| Burning Rock Biotech LTD | SPONSORED ADS | 12233L107 | $22.5M | 8,020,625 | 2.9% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $20.2M | 100,000 | 2.6% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.6M | 499,853 | 2.4% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $18.0M | 12,000,000 | 2.3% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $17.7M | 498,329 | 2.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $16.5M | 3,807,876 | 2.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $13.8M | 543,603 | 1.8% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $11.3M | 1,642,244 | 1.5% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $11.0M | 1,800,000 | 1.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $8.3M | 1,000,000 | 1.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $7.4M | 1,495,981 | 1.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $7.0M | 2,011,853 | 0.9% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $4.4M | 768,913 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.3M | 399,974 | 0.6% |
| Sutro Biopharma Inc | COM | 869367102 | $4.2M | 901,836 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.8M | 729,077 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.9M | 1,502,866 | 0.2% |
| Argenx SE(ARGX)Put | SPONSORED ADR | 04016X101 | $1.7M | 4,500 | 0.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.7M | 92,602 | 0.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $1.5M | 473,070 | 0.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.0M | 28,696 | 0.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $965.5K | 31,336 | 0.1% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $739.6K | 739,649 | 0.1% |
| Merus N V | COM | N5749R100 | $394.8K | 21,457 | 0.1% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $84.0K | 119,966 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $18.6K | 89,886 | 0.0% |